Athira Pharma, Inc.
ATHA
$0.36
$0.01885.51%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 39.06% | 47.80% | -7.01% | -1.98% | 3.47% |
Total Depreciation and Amortization | 0.00% | 0.00% | 0.41% | 0.00% | -1.22% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -27.73% | -22.99% | -5.10% | 25.11% | 23.79% |
Change in Net Operating Assets | 45.24% | -633.46% | 113.30% | 154.35% | -74.32% |
Cash from Operations | 43.62% | -12.99% | -3.10% | 13.46% | 1.86% |
Capital Expenditure | -- | -- | 100.00% | -460.00% | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -161.42% | -115.59% | -32.16% | 103.82% | 104.13% |
Cash from Investing | -161.42% | -115.59% | -32.09% | 103.68% | 104.05% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | 183.33% | -91.89% | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -- | 183.33% | -91.89% | -- | -- |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 23.53% | -479.06% | -213.52% | 134.32% | 35.38% |